Look through per level per nominee, not full beneficial shareholder analysis which cost $2k -$3k per report. Keep trying mate....actually you won't win cause I've used the reports before at board level & know all the pricing, across competitors. Keep telling me I'm wrong....it just makes you look less intelligent with every post. #Gobbleroftheyear
Look through per level per nominee, not full beneficial...
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
-0.005(2.33%) |
Mkt cap ! $399.0M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 22.0¢ | 20.8¢ | $661.1K | 3.116M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 345840 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 1257898 | 22 |
View Market Depth
| Last trade - 11.55am 04/07/2024 (20 minute delay) ? |
| BRN (ASX) Chart |